Found 11 results

Search term: MF = 'C_{38}H_{64}N_{8}O_{14}'
ChemSpider 2D Image | (2R)-N-[(4aS,16aR,19R,22S,23S)-6,18-Dihydroxy-22-isopropyl-7-(methoxymethyl)-19-methyl-5,8,11,17,20,24-hexaoxodocosahydro-13H,22H-dipyridazino[6,1-f:6',1'-o][1,4,7,10,13,16]oxapentaazacyclononadecin-2 3-yl]-2-hydroxy-2-[(2S,5S,6S)-2-hydroxy-5-isobutyl-6-methyltetrahydro-2H-pyran-2-yl]propanamide | C38H64N8O14

(2R)-N-[(4aS,16aR,19R,22S,23S)-6,18-Dihydroxy-22-isopropyl-7-(methoxymethyl)-19-methyl-5,8,11,17,20,24-hexaoxodocosahydro-13H,22H-dipyridazino[6,1-f:6',1'-o][1,4,7,10,13,16]oxapentaazacyclononadecin-2 3-yl]-2-hydroxy-2-[(2S,5S,6S)-2-hydroxy-5-isobutyl-6-methyltetrahydro-2H-pyran-2-yl]propanamide

  • Molecular FormulaC38H64N8O14
  • Average mass856.960 Da
  • Monoisotopic mass856.454224 Da
  • ChemSpider ID59700701

  • defined stereocentres - 9 of 10 defined stereocentres

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

(2R)-N-[(4aS,16aR,19R,22S,23S)-6,18-Dihydroxy-22-isopropyl-7-(methoxymethyl)-19-methyl-5,8,11,17,20,24-hexaoxodocosahydro-13H,22H-dipyridazino[6,1-f:6',1'-o][1,4,7,10,13,16]oxapentaazacyclononadecin-2 3-yl]-2-hydroxy-2-[(2S,5S,6S)-2-hydroxy-5-isobutyl-6-methyltetrahydro-2H-pyran-2-yl]propanamid [German] [ACD/IUPAC Name]
(2R)-N-[(4aS,16aR,19R,22S,23S)-6,18-Dihydroxy-22-isopropyl-7-(methoxymethyl)-19-methyl-5,8,11,17,20,24-hexaoxodocosahydro-13H,22H-dipyridazino[6,1-f:6',1'-o][1,4,7,10,13,16]oxapentaazacyclononadecin-2 3-yl]-2-hydroxy-2-[(2S,5S,6S)-2-hydroxy-5-isobutyl-6-methyltetrahydro-2H-pyran-2-yl]propanamide [ACD/IUPAC Name]
(2R)-N-[(4aS,16aR,19R,22S,23S)-6,18-Dihydroxy-22-isopropyl-7-(méthoxyméthyl)-19-méthyl-5,8,11,17,20,24-hexaoxodocosahydro-13H,22H-dipyridazino[6,1-f:6',1'-o][1,4,7,10,13,16]oxapentaazacyclononadécin-2 3-yl]-2-hydroxy-2-[(2S,5S,6S)-2-hydroxy-5-isobutyl-6-méthyltétrahydro-2H-pyran-2-yl]propanamide [French] [ACD/IUPAC Name]
(2R)-N-[(4aS,7R,16aR,19R,22S,23S)-6,18-Dihydroxy-22-isopropyl-7-(methoxymethyl)-19-methyl-5,8,11,17,20,24-hexaoxodocosahydro-13H,22H-dipyridazino[6,1-f:6',1'-o][1,4,7,10,13,16]oxapentaazacyclononadeci n-23-yl]-2-hydroxy-2-[(2S,5S,6S)-2-hydroxy-5-isobutyl-6-methyltetrahydro-2H-pyran-2-yl]propanamid [German] [ACD/IUPAC Name]
(2R)-N-[(4aS,7R,16aR,19R,22S,23S)-6,18-Dihydroxy-22-isopropyl-7-(methoxymethyl)-19-methyl-5,8,11,17,20,24-hexaoxodocosahydro-13H,22H-dipyridazino[6,1-f:6',1'-o][1,4,7,10,13,16]oxapentaazacyclononadeci n-23-yl]-2-hydroxy-2-[(2S,5S,6S)-2-hydroxy-5-isobutyl-6-methyltetrahydro-2H-pyran-2-yl]propanamide [ACD/IUPAC Name]
(2R)-N-[(4aS,7R,16aR,19R,22S,23S)-6,18-Dihydroxy-22-isopropyl-7-(méthoxyméthyl)-19-méthyl-5,8,11,17,20,24-hexaoxodocosahydro-13H,22H-dipyridazino[6,1-f:6',1'-o][1,4,7,10,13,16]oxapentaazacyclononadéci n-23-yl]-2-hydroxy-2-[(2S,5S,6S)-2-hydroxy-5-isobutyl-6-méthyltétrahydro-2H-pyran-2-yl]propanamide [French] [ACD/IUPAC Name]
Aurantimycin

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

Density: 1.4±0.1 g/cm3
Boiling Point:
Vapour Pressure:
Enthalpy of Vaporization:
Flash Point:
Index of Refraction: 1.603
Molar Refractivity: 211.9±0.4 cm3
#H bond acceptors: 22
#H bond donors: 8
#Freely Rotating Bonds: 8
#Rule of 5 Violations: 3
ACD/LogP: -3.99
ACD/LogD (pH 5.5): -3.98
ACD/BCF (pH 5.5): 1.00
ACD/KOC (pH 5.5): 1.00
ACD/LogD (pH 7.4): -4.03
ACD/BCF (pH 7.4): 1.00
ACD/KOC (pH 7.4): 1.00
Polar Surface Area: 289 Å2
Polarizability: 84.0±0.5 10-24cm3
Surface Tension: 70.7±5.0 dyne/cm
Molar Volume: 617.3±5.0 cm3

Click to predict properties on the Chemicalize site


Advertisement